Jubilant Draximage Radiopharmacies Inc.

Form 483 issued March 5, 2024 · Orlando, Florida

Inspection
Mar 5, 2024
Observations
6
Pages
4
FEI number
3009339218

In short: On March 5, 2024, FDA issued a Form 483 with 6 observations to Jubilant Draximage Radiopharmacies Inc. in Orlando, Florida (FEI 3009339218) after an inspection that ran Mar 5, 2024. The investigators were Jared P. Stevens and Jessica P. McAlister.

What FDA observed

Preview: the opening words of each observation
  1. 01
    FDCA 501(a)(2)(A)

    Personnel were observed perfonning aseptic processing outside of…

  2. 02
    FDCA 501(a)(2)(A)

    Personnel were observed conducting aseptic manipulations where the movement of 11 first air" in the ISO…

  3. 03
    FDCA 501(a)(2)(A)

    EM Pl.OYEE(S) SIGNATURE Use of non-sterile disinfecting agents and cleaning pads in…

  4. 04
    FDCA 501(a)(2)(A)

    Smoke studies were inadequately…

2 more observations

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Jubilant Draximage Radiopharmacies Inc.?

FDA listed 6 observations on this Form 483. The opening words of each observation are shown on this page.

Who inspected Jubilant Draximage Radiopharmacies Inc.?

Jared P. Stevens and Jessica P. McAlister are named on this Form 483, for the inspection of Mar 5, 2024. Each investigator has a profile showing what they cite most.

When was Jubilant Draximage Radiopharmacies Inc. inspected by FDA?

The inspection ran Mar 5, 2024, and the Form 483 is dated March 5, 2024.

How do I get the full Form 483 for Jubilant Draximage Radiopharmacies Inc.?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free